Valeo Financial Advisors LLC Has $2.45 Million Holdings in Intuitive Surgical, Inc. $ISRG

Valeo Financial Advisors LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,503 shares of the medical equipment provider’s stock after purchasing an additional 253 shares during the period. Valeo Financial Advisors LLC’s holdings in Intuitive Surgical were worth $2,447,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Aaron Wealth Advisors LLC boosted its stake in Intuitive Surgical by 0.8% in the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after purchasing an additional 19 shares during the period. Crown Wealth Group LLC boosted its stake in Intuitive Surgical by 4.8% in the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock worth $218,000 after purchasing an additional 20 shares during the period. FSM Wealth Advisors LLC boosted its stake in Intuitive Surgical by 3.8% in the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock worth $270,000 after purchasing an additional 20 shares during the period. CFO4Life Group LLC boosted its stake in Intuitive Surgical by 4.8% in the 1st quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock worth $216,000 after purchasing an additional 20 shares during the period. Finally, J. W. Coons Advisors LLC boosted its stake in Intuitive Surgical by 1.4% in the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock worth $741,000 after purchasing an additional 20 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 23rd. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Saturday, September 27th. Piper Sandler restated an “overweight” rating and set a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Finally, BTIG Research restated a “buy” rating and set a $571.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 1st. Fourteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $594.19.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $449.69 on Tuesday. The firm’s 50-day moving average is $462.67 and its 200-day moving average is $499.82. The stock has a market cap of $161.20 billion, a price-to-earnings ratio of 62.72, a PEG ratio of 4.74 and a beta of 1.61. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. Intuitive Surgical’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.78 EPS. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In other news, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.